We are live on
!
Find out more
PC
Polar Capital Portfolio holdings
AUM
$13.5B
1-Year Est. Return
55.9%
This Fund
S&P 500
This Quarter
Est. Return
+3.49%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$6.26B
AUM Growth
+$473M
(+8.2%)
Cap. Flow
+$398M
Cap. Flow
% of AUM
6.35%
Top 10 Holdings %
Top 10 Hldgs %
23.68%
Holding
293
New
38
Increased
125
Reduced
71
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$53.8M |
| 2 |
Elevance Health
ELV
|
+$34.6M |
| 3 |
AET
Aetna Inc
AET
|
+$33.5M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$32.4M |
| 5 |
Ametek
AME
|
+$29.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$48.5M |
| 2 |
Merck
MRK
|
+$37.3M |
| 3 |
Amgen
AMGN
|
+$35M |
| 4 |
Edwards Lifesciences
EW
|
+$29.3M |
| 5 |
Booz Allen Hamilton
BAH
|
+$26.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 23.24% |
| 2 | Technology | 21.39% |
| 3 | Healthcare | 21.13% |
| 4 | Communication Services | 9.82% |
| 5 | Industrials | 4.95% |
Similar funds
ECM
FAAS
WAM
FS
NIMC
TI
VIM
PS
Polar Capital's Q4 2016 Portfolio in Review
As of Q4 2016, Polar Capital held 293 positions worth $6.26B, up 8.2% from $5.79B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Polar Capital deployed $398M of net new capital in Q4 2016, opening 38 new positions and adding to 125 existing holdings. Its largest new stake was Aetna Inc: 279,500 shares worth $34.7M.
By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $48.5M trimmed.
- Polar Capital's largest Q4 2016 buy was Aetna Inc: 279,500 shares worth $34.7M.
- Polar Capital added most to Alexion Pharmaceuticals in Q4 2016, an estimated $53.8M increase.
- Polar Capital's biggest Q4 2016 reduction was Johnson & Johnson, cutting an estimated $48.5M.
- Polar Capital fully exited Edwards Lifesciences in Q4 2016, selling an estimated $29.3M.
- Polar Capital's ten largest holdings make up 24% of its $6.26B portfolio in Q4 2016.
- Polar Capital opened 38 new positions and closed 38 in Q4 2016.
- Polar Capital's portfolio value rose 8.2% quarter-over-quarter to $6.26B.
Based on Polar Capital's 13F filing for Q4 2016, filed 14 Feb 2017.